Frontiers | Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study - Yimer - 2019 - British Journal of Haematology - Wiley Online Library
DVdSC (weekly cycles1-8) Bortezomib-Daratumumab-Dexamethasone Ver1
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study - ScienceDirect
Multiple myeloma current treatment algorithms | Blood Cancer Journal
Addition of daratumumab to multiple myeloma backbone regimens significantly improves clinical outcomes: a systematic review and meta-analysis of randomised controlled trials | Scientific Reports
DVd - Darzalex + Velcade + dex - Myeloma | ChemoExperts
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients | British Journal of Cancer
Doxil, Vincritine, Reduced Frequency Dexamethasone in Combination with Thalidomide (DVd-T) Is Associated with Higher Overall and Progression Free Survival as Compared to DVd in Patients with Multiple Myeloma (MM). - ScienceDirect
Next-generation multiple myeloma treatment: a pharmacoeconomic perspective - ScienceDirect
Treatment of relapsed and refractory multiple myeloma | Haematologica
CASTOR study design. RRMM = relapsed or refractory multiple myeloma;... | Download Scientific Diagram
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion
Multiple myeloma current treatment algorithms | Blood Cancer Journal
Overall survival in a cohort of multiple myeloma patients treated with... | Download Scientific Diagram
VAD and similar alternate regimens | Download Table
Hull University Teaching Hospitals and North Lincolnshire NHS Trusts Haematology Multidisciplinary Team Guideline and Pathway Mu
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion
Hemato | Free Full-Text | Why Immunotherapy Fails in Multiple Myeloma
Pharmaceuticals | Free Full-Text | Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment
The DVD Regimen After Myeloma Progression
